Search Within

Maria Michelle Rubinstein

Formats
  1. Journal Article (21)
  2. Meeting Abstract (13)
  3. Review (3)
Groups
  1. GDMT, Medicine (37)
  2. Gynecologic Medicine Service (37)
  3. Gynecology Disease Management Team (37)
  4. Solid Tumor Oncology Division (37)
  5. Weinberg Fellows (37)
  6. Department of Medicine (33)

More Groups

People
  1. Vicky Makker (28)
  2. Carol Aghajanian (21)
  3. Alexia Iasonos (15)
  4. Rachel Grisham (15)
  5. Britta Weigelt (13)
  6. Claire Friedman (13)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Gynecologic Oncology (13)
  2. International Journal of Gynecological Cancer (4)
  3. Journal of Clinical Oncology (4)
  4. Gynecologic Oncology Reports (3)
  5. Clinical Cancer Research (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (14)
  2. Lippincott Williams & Wilkins (6)
  3. American Society of Clinical Oncology (4)
  4. American Association for Cancer Research (3)
  5. Elsevier B.V. (3)
  6. Nature Publishing Group (2)

More Publishers

Results (37)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer
    Journal Article

    Stasenko, M.; Tunnage, I.; Ashley, C. W.; Rubinstein, M. M.; Latham, A. J.; Da Cruz Paula, A.; Mueller, J. J.; Leitao, M. M. Jr; Friedman, C. F.; Makker, V.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Optimizing immunotherapy for gynecologic cancers
    Review

    Rubinstein, M. M.; Makker, V.
    Current Opinion in Obstetrics & Gynecology (2020)

    Fulltext@MSK | Save
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • The prognostic significance of white adipose tissue inflammation in advanced-stage, high-grade, and serous endometrial cancers
    Meeting Abstract

    Broach, V.; Iyengar, N. M.; Zhou, X. K.; Wang, H.; Giri, D. D.; Williams, S.; Abu-Rustum, N.; Rubinstein, M. M.; Dannenberg, A. J.; Makker, V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Retreatment with carboplatin and paclitaxel for recurrent endometrial cancer: A retrospective study of the Memorial Sloan Kettering Cancer Center experience
    Journal Article

    Rubinstein, M.; Halpenny, D.; Makker, V.; Grisham, R. N.; Aghajanian, C.; Cadoo, K.
    Gynecologic Oncology Reports (2019)

    Fulltext@MSK | Save
  • Palliation and pleurodesis in malignant pleural effusion: The role for tunneled pleural catheters
    Journal Article

    Suzuki, K.; Servais, E. L.; Rizk, N. P.; Solomon, S. B.; Sima, C. S.; Park, B. J.; Kachala, S. S.; Zlobinsky, M.; Rusch, V. W.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save